Year archive

Oramed Pharmaceuticals Inc. — 2026 filings

All 32 regulatory filings released by Oramed Pharmaceuticals Inc. (ORMP) in 2026, sourced directly from the official regulator.

32 Filings

2026 Period

2026 filings (32)

Filing	Released	Lang
4 - ORAMED PHARMACEUTICALS INC. (0001176309) (Issuer) Director's Dealing	2026-03-18	English
4 - ORAMED PHARMACEUTICALS INC. (0001176309) (Issuer) Director's Dealing	2026-03-18	English
4 - ORAMED PHARMACEUTICALS INC. (0001176309) (Issuer) Director's Dealing	2026-03-18	English
4 - ORAMED PHARMACEUTICALS INC. (0001176309) (Issuer) Director's Dealing	2026-03-18	English
8-K - ORAMED PHARMACEUTICALS INC. (0001176309) (Filer) Regulatory Filings	2026-02-20	English
SCHEDULE 13G/A Filing Major Shareholding Notification	2026-02-09	English
4 Filing Director's Dealing	2026-01-29	English
SCHEDULE 13D Filing Major Shareholding Notification	2026-01-29	English
4 Filing Director's Dealing	2026-01-29	English
4 Filing Director's Dealing	2026-01-29	English
4 Filing Director's Dealing	2026-01-29	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP - KIDRON MIRIAM Director's Dealing	2026-01-22	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP - KIDRON MIRIAM Director's Dealing	2026-01-22	English
4 Filing Director's Dealing	2026-01-21	English
FORM 8K-Lifeward will acquire all of the outstanding equity interests in Oratech from the Company; Lifeward will issue to the Company ordinary shares and pre-funded warrants equal to up to 49.99% M&A Activity	2026-01-15	English
FORM 8K-Lifeward will acquire all of the outstanding equity interests in Oratech from the Company; Lifeward will issue to the Company ordinary shares and pre-funded warrants equal to up to 49.99% Report Publication Announcement	2026-01-15	English
8-K Filing Regulatory Filings	2026-01-14	English
Oramed will transfer POD™ platform to Lifeward, Oramed will receive 49.9% beneficial ownership interest in Lifeward M&A Activity	2026-01-13	English
Oramed will transfer POD™ platform to Lifeward, Oramed will receive 49.9% beneficial ownership interest in Lifeward Regulatory Filings	2026-01-13	English
Oramed Receives $18 Million Payment from Scilex Holdings; approved a cash dividend t of $0.25 per share, ex-dividend date of January 16, 2026 with disbursement scheduled for January 26, 2026 Notice of Dividend Amount	2026-01-07	English
Oramed Receives $18 Million Payment from Scilex Holdings; approved a cash dividend t of $0.25 per share, ex-dividend date of January 16, 2026 with disbursement scheduled for January 26, 2026 Report Publication Announcement	2026-01-07	English
8-K Filing Regulatory Filings	2026-01-07	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Director's Dealing	2026-01-06	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Report Publication Announcement	2026-01-06	English
4 Filing Director's Dealing	2026-01-05	English
4 Filing Director's Dealing	2026-01-05	English
4 Filing Director's Dealing	2026-01-05	English
4 Filing Director's Dealing	2026-01-05	English
4 Filing Director's Dealing	2026-01-05	English
4 Filing Director's Dealing	2026-01-05	English
4 Filing Director's Dealing	2026-01-02	English
4 Filing Director's Dealing	2026-01-02	English

Filings by year

2026 32 filings
2025 80 filings
2024 124 filings
2023 114 filings
2022 131 filings
2021 172 filings
2020 112 filings
2019 133 filings
2018 85 filings
2017 96 filings
2016 32 filings
2015 38 filings
2014 64 filings
2013 54 filings
2012 62 filings
2011 43 filings
2010 44 filings
2009 27 filings
2008 40 filings
2007 31 filings
2006 20 filings
2005 19 filings
2004 14 filings
2003 7 filings
2002 1 filing